# A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With Tuberculosis

> **NCT07708779** · PHASE1 · RECRUITING · sponsor: **University Medical Center Groningen** · enrollment: 8 (estimated)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Isoniazid

## Key facts

- **NCT ID:** NCT07708779
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-07-16
- **Final completion:** 2026-07-16
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708779, "A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With Tuberculosis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07708779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*